C2 C Wealth Management, LLC Pfizer Inc Transaction History

C2 C Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $2.39 Million - $3.11 Million	-91,598 Reduced 85.07%	16,076 $462,000
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $725,234 - $847,726	22,600 Added 26.57%	107,674 $3.57 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $750,609 - $868,437	20,781 Added 32.32%	85,074 $3.12 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $763,929 - $994,524	19,394 Added 43.19%	64,293 $2.62 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $292 - $381	-7 Reduced 0.02%	44,899 $2.3 Million
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $4,682 - $5,715	-107 Reduced 0.24%	44,906 $2 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $252,285 - $299,131	-5,422 Reduced 10.75%	45,013 $2.31 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $567,391 - $703,069	-12,402 Reduced 19.74%	50,435 $2.52 Million
Q4 2021 Feb 23, 2022	BUY	$41.32 - $61.25 $2.6 Million - $3.85 Million	62,837 New	62,837 $3.71 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on C2 C Wealth Management, LLC with notifications on news.